Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Issue: Jan/Feb 2023 - Volume 27, Number 1
View All Articles in Issue
Page(s): 53
Download in electronic PDF format for $75
Abstract: A formulation for preparing Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, erlotinib, formulations, oral suspensions, antineoplastic agent, epidermal growth factor receptor inhibitor, EGF receptor blocker, anticancer agent, cancer, tumor
Related Categories: CANCER AND AIDS, EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS